Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma

NCT01757626 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

186

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

BIOLOGICAL: Hu3F8 With GM-CSF
BIOLOGICAL: Hu3F8 With GM-CSF

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]